Autopsy report · NCT00164788

A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole

“No suitable patients and many patients refused the study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 2 months after it had already started.
• Ran for about 6 years 6 months before it stopped.
• 7 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Chinese University of Hong Kong

Sponsor type

University, hospital or other

Conditions

Gastrointestinal Hemorrhage

Interventions

Intravenous bolus injection of esomeprazole; Oral esomeprazole

Participants

7

Sites

1

Countries

China

Trials that died the same way

• Antioxidant Supplement and Reduction of Metachronous Adenomas of the Large Bowel: a Double Blind Randomized Trial
  “50% of eligible patients refused to enter the study” (81% match in meaning)
• Xenogenic Keratoplasty From Porcine Cornea
  “there was not enough patients recruited in this study” (79% match in meaning)
• Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
  “The study was stopped due to difficulties in including patients” (78% match in meaning)
• Cannabinoids in Bipolar Affective Disorder
  “study was never started and no patients were ever enrolled” (73% match in meaning)
• Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
  “The study was stopped because there were not enough eligible patients to complete the study.” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.